We undertook a meta-analysis of six Crohn's disease genomewide association studies (GWAS) comprising 6,333 affected individuals (cases) and 15,056 controls and followed up the top association signals in 15,694 cases, 14,026 controls and 414 parent-offspring trios. We identified 30 new susceptibility loci meeting genome-wide significance (P < 5 × 10 −8 ). A series of in silico analyses highlighted particular genes within these loci and, together with manual curation, implicated functionally interesting candidate genes including SMAD3, ERAP2, IL10, IL2RA, TYK2, FUT2, DNMT3A, DENND1B, BACH2 and TAGAP. Combined with previously confirmed loci, these results identify 71 distinct loci with genome-wide significant evidence for association with Crohn's disease.
l e t t e r s significant hits from our earlier meta-analysis (Table 1) , demonstrated association with P < 10 −5 . A Manhattan plot is shown in Supplementary  Figure 2 . We followed up 51 of the regions, representing new loci associated at P < 5 × 10 −6 , by genotyping the most significant SNPs in an independent panel of 15,694 Crohn's disease cases, 14,026 controls and 414 parent-offspring trios (Supplementary Table 2) .
Variants within 30 distinct new loci met a genome-wide significance threshold of P < 5 × 10 −8 for association with Crohn's disease in the combined discovery plus replication panel, with at least nominal association in the replication panel ( Table 2) . Two additional loci, encompassing CARD9 and IL18RAP, had previously been reported as associated with Crohn's disease in a candidate gene study 7 and were here both replicated and confirmed at P < 5 × 10 −8 . Another five loci were identified at genome-wide significance in GWAS published subsequent to our replication experiment being designed. One, the FUT2 locus, was found in a recent adult Crohn's disease GWAS 6 . Four more (in ZMIZ1 at 10q22, in IL27 at 16p11, 19q13 and 22q12) were identified in a pediatric IBD population 5 ; these were replicated here in our current sample set. Two further loci had produced suggestive evidence of association with replication in our earlier study 1 . Here, these loci clearly exceeded the genome-wide significance threshold in the meta-analysis alone and, given the previous replication evidence, were not followed up further. Thus, cumulatively, 39 loci can now be added to the 32 confirmed Crohn's disease susceptibility loci identified at the time of our original meta-analysis 1 . We did not observe statistically significant heterogeneity of the odds ratios (Breslow Day test P < 0.05 after Bonferroni correction; Supplementary Table 3 ) between the panels from our 15 different Tables 1 and 2) for any of the 71 loci, nor did we observe any evidence of interaction between the associated loci ( Supplementary Fig. 3 ).
Regional association plots of all 71 susceptibility loci, including the underlying genes, are shown in detail in Supplementary Figure 4 , and complete genotype data, including odds ratios and allele frequencies, are shown in Supplementary Tables 3 and 4. Five loci showed evidence for more than one independently associated variant ( Table 2) . Although six of the 30 newly discovered regions contain just a single gene, which is thereby strongly implicated in Crohn's disease pathogenesis (for example, SMAD3, NDFIP1 and BACH2), 22 of these regions include more than one gene within the associated interval ( Table 2) . We thus applied additional in silico analyses to refine the list of functional candidate genes further. These analyses were (i) interrogation of a publicly The table lists Crohn's disease susceptibility loci newly identified since the first meta-analysis 1 with P < 5 × 10 −8 in the combined analysis (discovery plus replication sample) and P < 0.05 in the replication stage. Seven of these loci have previously been reported (see footnotes b and e below). Column headings and abbreviations are as described in table 1. Additional abbreviations are as follows: CRC, colorectal cancer; CRP, C-reactive protein; TGs, triglycerides; PC, prostate cancer; HSV, human simplex virus; CAD, coronary artery disease; CLL, chronic lymphocytic leukemia; BMD, bone mineral density; B12, serum vitamin B12 levels; HP, Helicobacter pylori; AA, alopecia areata.
l e t t e r s available expression quantitative trait loci (eQTL) database 8 , which identified genes for which expression correlates with genotype at our most associated SNP (Supplementary Note), (ii) use of 1000 Genomes Project Pilot sequence data and HapMap3 data to identify genes containing non-synonymous variants in strong linkage disequilibrium (r 2 > 0.5) with the focal SNP within each region (for details on coding SNPs, see Supplementary Table 5 ) and (iii) use of GRAIL 9 to identify nonrandom and evidence-based connectivity between the genes in the 71 confirmed Crohn's disease loci. Specifically, GRAIL evaluates each gene within a Crohn's disease-associated locus for non-random correlation with genes in the other 70 loci through word-usage in PubMed abstracts related to the gene ( Fig. 1) . Summary results of these analyses are shown in the rightmost column of Table 1 and Table 2 and in Supplementary Table 6. Highlighted genes are described briefly in Box 1, as are genes that constitute particularly noteworthy candidates from intervals containing one or few genes. Although we believe that these evidence-based approaches are helpful in identifying likely functional candidates, in some instances, the different techniques highlight different genes. This reflects uncertainty as to which genes are causal and emphasizes the need for functional studies.
We identified 30 new signals here beyond those described in the earlier meta-analysis 1 and other subsequent publications. The discovery of these new associations was driven primarily by increased power arising from the expanded sample size rather than improved imputation, as more than two-thirds of the newly discovered loci have good proxies (r 2 > 0.8) on the arrays used in the earlier studies (Illumina 300K and Affymetrix 500K). Extending this argument beyond the current analysis, it seems likely that many more loci of modest effect size still await discovery.
For many of the loci, associations have been reported previously in other complex diseases, comprising mostly chronic inflammatory disorders (Tables 1 and 2 ). Such diseases can cluster both within families and within individuals, reflecting shared genetic risk factors. For example, IBD and ankylosing spondylitis can co-segregate and both are associated with IL23R (refs. 2,10) and TNFSF15 (refs. 11,12) . The IL10 locus was previously associated with ulcerative colitis 13 and was identified as a new Crohn's disease risk locus here. Thus, IL10 is a generic IBD locus, which is a functionally intuitive finding of potential therapeutic significance.
For loci previously associated with other inflammatory diseases, the direction of effect in Crohn's disease is usually the same; however, in five instances, the risk allele for one disease appears to be protective in another disease (see penultimate column in Tables 1 and 2) . In most such instances, functional annotation suggests modulation of T cells and other immune pathways. Indeed, GRAIL highlights a number of such genes. These inverse associations may reflect overlap in the pathways by which the host regulates effector functions in defense and regulatory functions in self tolerance. This is a delicate balance and, in the face of competing requirements, selection pressures may have conferred an advantage for divergent alleles in a cell-and environment-dependent manner.
The associated SNP rs281379 at 19q13, also recently identified in another study 6 , is highly correlated (r 2 > 0.80) with a common nonsense variant (rs601338, also known as c.428G>A or p.Trp142X) at FUT2. This is classically referred to as the non-secretor variant, as individuals homozygous for this null allele do not secrete blood group antigens at epithelial surfaces. Recently, non-secretors were identified as having near-complete protection from symptomatic GII.4 norovirus infection 14 , and the same null allele is identified here as a risk factor for Crohn's disease. This suggests one potential elusive link between infection and immune-mediated disease.
In contrast to the implication of coding variation in FUT2, our previous data showed that most Crohn's disease-associated SNPs were not in linkage disequilibrium with coding polymorphisms 1 , suggesting that regulatory effects are likely to be a more common mechanism of disease susceptibility. Providing further direct evidence for this, we here identified a number of new eQTL effects (Table 2 and Supplementary Note), including CARD9 (logarithm of the odds (LOD) = 12.4), ERAP2 (LOD = 47.2) and TNFSF11 (also known as RANKL) (LOD = 5.9). The latter maps adjacent to but outside the associated recombination interval, suggesting another potential longrange cis-regulatory effect as previously described for PTGER4 in Crohn's disease 4 . RANKL has pleiotropic immunological effects and also stimulates osteoclast activity. This finding may be relevant to the osteoporosis clinically associated with Crohn's disease. Figure 1 Gene relationships across implicated loci (GRAIL) pathway analysis. Links between genes at 23 of 71 Crohn's disease-associated loci which scored P < 0.01 using GRAIL. Specifically, of the 71 Crohn's disease-associated SNPs, 69 are in linkage disequilibrium intervals containing or within 50 kb of at least one gene. In total, there were 355 genes implicated by proximity to these 69 SNPs. Each observed association was scored with GRAIL, which takes each gene mapping within Crohn's disease-associated intervals and evaluates for each whether it is non-randomly linked to the other genes through word usage in PubMed abstracts. The 23 SNPs shown in the outer circle are significant at P < 0.01, indicating that the regions which they tag contain genes which are more significantly linked to genes in the other 68 regions than expected by chance at that level. The lines between genes represent individually significant connections that contribute to the positive signal, with the thickness of the lines being inversely proportional to the probability that a literature-based connection would be seen by chance. To accurately assess the statistical significance of this set of connections, we conducted simulations in which we selected 1,000 sets of 69 SNPs implicating in total 355 genes ± 18 genes (5%) (selecting the SNPs randomly and using rejection sampling, only taking lists that implicated the same number of genes). Each of those 1,000 sets was scored with GRAIL. The mean number of P < 0.01 hits in a simulated list was 0.91, with a range in the 1,000 sets from 0 to 11, suggesting that the likelihood of observing 23 hits with P < 0.01 is far less than 0.1%.
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Given the importance of regulatory effects, it is notable that variants within the gene encoding a key mediator of epigenetic regulation, DNMT3A (the DNA methyltransferase 3A gene), should be associated with Crohn's disease. By inducing transcriptional silencing, DNMT3A is known to play an important role in immunoregulation. For example, DNMT3A methylates IL-4 and IFN-γ promoters following T-cell-receptor stimulation, hence regulating T-cell polarization 15 , and induces dynamic regulation of TNF-α transcription following lipopolysaccharide exposure in leukocytes 16 . Genetically determined alterations in DNMT3A activity could thus have far-reaching effects.
The 32 loci described up until 2008 explained approximately 20% of Crohn's disease heritability. Adding the 39 loci described since that time increases the proportion of heritability explained to only 23.2%. This pattern of common alleles explaining a logarithmically decreasing fraction of heritability (Fig. 2) is consistent with a recent model of effect size distribution 17 , which predicted (based on the previous Crohn'sdisease meta-analysis) that our current sample size would likely identify 48 new loci. Furthermore, it is likely that more high-frequency Crohn's disease risk alleles of even smaller effect size remain unidentified: the same model predicts that 140 loci would be identified by a sample size of 50,000, but these loci would explain only a few more percent of Crohn's disease heritability. It is clear, therefore, that larger GWAS alone will not explain all of the missing heritability in Crohn's disease.
One key shortcoming of our current model of heritability explained by these loci is a direct consequence of the extent to which GWAS tag SNPs are often imperfect proxies for causal alleles and thus substantially underestimate the true attributable risk. For example, the best tag SNP at the NOD2 locus in our meta-analysis appears to explain just 0.8% of genetic variance, whereas the three NOD2 coding mutations
Box 1 Noteworthy genes within loci newly implicated in Crohn's disease pathogenesis
Although we highlight these as interesting genes, we do not yet have data to confirm causality.
 VAMP3 (1p36) encodes vesicle-associated membrane protein 3. Following bacterial stimulation of TNF-α production within macrophages, VAMP3 interacts with SNARE proteins first on the trans-Golgi network, where TNF-α is taken up, and then on the cell membrane, where TNF-α is released 19 . VAMP3 also plays a role in cell migration and adhesion by trafficking molecules such as β1 integrin to the cell surface, and it has been implicated in autophagy 20 .
 MUC1-SCAMP3 (1q22). MUC1 encodes a key constituent of mucus, which is the physical barrier that protects the intestinal epithelium from gut bacteria. MUC1 overexpression and hypoglycosylation have been reported in IBD 21 , and Muc1 knockdown mice exhibit increased small intestinal damage after C. jejuni infection 22 . Secretory carrier membrane protein 3 (encoded by SCAMP3) regulates EGFR trafficking within endosomal membranes 23 . Secretory carrier membrane protein 3 is manipulated by intracellular salmonellae to acquire nutrients and influence host immune responses 24 .
 DENND1B (1q31) has recently been associated with asthma 25 and is expressed in dendritic and natural killer cells. DENN-containing proteins influence MAP-kinase signaling pathways and DENND1B, in particular, has been predicted to interact with TNFR1.
 IL10 (1q32). Association with Crohn's disease follows its recent implication in ulcerative colitis 13 and the reporting of mutations in the IL10 receptors in extreme Crohn's disease in infancy 26 . Known to inhibit synthesis of pro-inflammatory cytokines within macrophages and Th1 cells, IL-10 also suppresses antigen-presenting cell activity. Knockdown of IL-10 in mice presents one of the best animal models of IBD.
 DNMT3A (2p23). DNA methyltransferase 3A is one of three key methyltransferase genes in humans, effecting epigenetic regulation of gene transcription by methylating cytosine residues within CpG islands. Among many other roles, this protein is known to determine dynamic regulation of both adaptive and innate immune mechanisms 15, 16 .
 GCKR (2p23) encodes an inhibitor of glucokinase, with the focal SNPs at this locus also correlating with both fibrinogen and CRP levels 27 .
 THADA (2p21) is expressed in the small intestine and appears to encode a death receptor-interacting protein, suggesting an apoptotic function 28 .  ERAP2 (5q15). Regulated by NF-κB, this gene encodes one of two human endoplasmic reticulum aminopeptidases, which work in concert to trim peptides for presentation on MHC class I and hence critically affect antigen presentation to T cells 29 . Ankylosing spondylitis is associated with this locus, but with a different pattern of associated variants 30 . Given the close clinical relationship between Crohn's disease and ankylosing spondylitis, and the strong association of HLA-B27 with the latter but not with the former, the divergent association of these closely related molecules is intriguing and will refocus interest on the MHC class I associations in Crohn's disease.
 NDFIP1 (5q31). Nedd4-family interacting protein 1 is a membrane protein involved in maintenance of the Golgi complex 31 . It is important for protein trafficking through exosomes and may play a role in rapid sequestration and removal of proteins during stress 32 .
 CPEB4 (5q35) encodes a regulator of protein translation and cell division and is a transcriptional target of RORγ t. Mouse work suggests that the product of CPEB4 is the effector by which RORγ t (a key determinant of Th17 cell differentiation) inhibits proliferation of thymocytes 33 .
 TAGAP (6q25). T-cell activation GTPase-activating protein, associated with multiple autoimmune diseases, was originally identified through its involvement in human T-cell activation and co-regulation with IL-2 (ref. 34).
 IL2RA (10p15) encodes part of the IL-2 receptor complex, thus mediating IL-2 signaling in host defense and regulating response to autoantigens by Tregs. The associated variants correlate with differential expression of IL2RA (CD25) on CD4 + naïve and memory T cells 35 , possibly affecting Foxp3 + Treg homeostasis 36 .
 FADS2 (11q12). Fatty acid desaturase 2 is predominantly located in the endoplasmic reticulum. Fads2 knockdown mice develop duodenal and ileocecal ulceration 37 .
 TNFSF11 (13q14), also called RANKL (receptor activator of nuclear factor kappa B) and ODF (osteoclast differentiation factor), encodes a member of the TNF cytokine family. RANKL stimulation of dendritic cells leads to proliferation of naive T cells and inducible Tregs 38 . It also regulates osteoclast activity and bone loss. Previous studies have demonstrated increased plasma levels in Crohn's disease 39 .
 SMAD3 (15q22). Phosphorylated following TGF-β signaling through its receptor, the SMAD3 protein complexes with SMAD4 and is then translocated to the nucleus to modulate target gene expression. SMAD3 plays a key role in the TGF-β-mediated induction of Foxp3 + regulatory T cells 40 , with SMAD3 deficiency reciprocally enhancing Th17. Reduced SMAD3 phosphorylation has been observed in IBD and may impair the immunosuppressive effect of TGF-β.
 TYK2 (19p13) encodes tyrosine kinase 2, a member of the JAK-signal transduction family. It is involved in cytokine signaling by IFN-γ, IL-12 and IL-23 among others, hence affecting Th1 and Th17 lineage development. TYK2 also plays an important role in TLR-mediated responses in dendritic cells, including IL-12 and IL-23 production, and TYK2 mutations predispose to opportunistic infection 41 .
 FUT2 (19q13) encodes α-(1,2)fucosyltransferase, which regulates expression of the Lewis AB0(H) histo-blood group of antigens on the surface of epithelial cells and in body fluids. It is strongly associated with Norovirus infection, as well as with with Helicobacter pylori infection and serum vitamin B12 levels 14, 42 . l e t t e r s themselves account for 5%. If an analogous situation applies to even a small fraction of the other 70 Crohn's disease susceptibility loci, the proportion of overall heritability explained will increase substantially. Indeed, one study of linkage disequilibrium between tag SNPs and causal variants in the heritability of human height 18 suggests that this effect might double the total fraction of heritability explained by GWAS SNPs. Coding variants identified here from the 1000 Genomes Project that are in strong linkage disequilibrium with the focal SNPs in several of our regions (Supplementary Table 5 ) thus now require direct assessment in order to explore this possibility.
Other factors will also account for the heritability gap, including uncertain epidemiological estimates of disease prevalence and total heritability, as well as our observation that several of the new regions contain more than one independent risk allele. The likelihood is that many more such effects will be identified. Indeed, detailed future analyses will play a key role in helping us to understand the absolute contribution of common causal alleles, as well as in identifying lower frequency variants and rare (even family-specific) mutations. By contrast, our lack of evidence for epistasis among the loci described here suggests that non-additive interactions among common risk alleles do not play an important role in the genetic architecture of Crohn's disease.
The current study has approximately doubled the number of confirmed Crohn's disease susceptibility loci. For many of these loci we have identified potentially causal genes, though confirmation of their role must await detailed fine mapping, expression and functional studies. Although the alleles detected only modestly affect disease risk, they continue to enhance our understanding of the genetic etiology of Crohn's disease. Looking for evidence of sub-phenotype associations represents an important future goal for the consortium. Thus, we are working toward sharing detailed genotype and clinical data to allow this. In the meantime, extensive resequencing, and large-scale fine mapping exercises using custom array-based technologies, are already underway and will further elucidate the pathogenic mechanisms of IBD.
URLs. Evoker v1.0, http://www.sanger.ac.uk/resources/software/ evoker/.
MethodS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
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All participating centers received approval from their local and national institutional review boards, and informed consent was obtained from all participants.
Imputation. GWAS imputation was carried out using BEAGLE 48, 49 and the HapMap3 reference samples from the CEU, TSI, MEX and GJT collections, with the exception of the early onset samples, which were imputed using the MACH program and the HapMap2 CEU reference samples. We carried forward a set of 953,242 autosomal markers (HapMap3 X-chromosome data were not available) that were polymorphic in at least one GWAS dataset for association analysis.
Test for association. We used genotype probabilities and empirical variances to summarize the standard 1 degree-of-freedom allele-based test for association as a z-score within each scan and combined the scores across all six datasets (inversely weighted by variance) to produce a single meta-statistic for each SNP. Odds ratios for replicated SNPs were estimated jointly from all case-control replication data available. Genomic positions were retrieved from NCBI's dbSNP build v130. Linkage disequilibrium regions around focal SNPs were defined by extending the region to the left for 0.1 cM or until another SNP with P < 10 −5 was reached, in which case the process was repeated from this SNP. Right-hand boundaries were defined in the same way.
Notably, the 'belge' and 'cedar2' GWAS collections showed more pronounced inflation than the other six collections (Supplementary Fig. 1 ). Three lines of evidence suggest that population structure in these collections is not driving the association at our 71 loci: (i) the principal component analysis-corrected association analysis of the belge and cedar2 samples implies that some of the inflation is due to population stratification (the belge inflation decreased from 1.2 to 1.15 and the cedar2 decreased from 1.30 to 1.05 after control for the principal components). Under the null hypothesis that all association signals were driven by this stratification, we would expect a consistent decrease in significance at our 71 loci after correction. By contrast, 28 loci become more significant in the belge subset and 37 loci become more significant in the cedar2 subset after correction, whereas the P values of the remaining loci did not change significantly. This is especially noteworthy because the additional degrees of freedom in the corrected test reduced power on average, and this evidence strongly affirms that the signals at these 71 loci are driven by disease association and not by confounding. For nearly all SNPs, the change before and after corrections was small (Supplementary Table 3) . (ii) The belge and cedar2 panels only represent 11% of our GWAS sample, making it difficult for them to drive associations in the full meta-analysis. We also tested for heterogeneity of odds ratios across all collections and found no significant differences after correcting for 71 tests (Supplementary Table 3 ). (iii) Some of the overall study inflation is due to true disease signal because the inflation factor decreases from 1.27 to 1.24 after excluding the known loci (with many more to be identified in the future).
Replication. We selected the most significantly associated SNP from each region and took this forward to replication. We carried out genotyping according to standard protocols associated with platforms described in Supplementary Table 2 . Samples with >10% missing data in any experiment were excluded from further analysis.
The following additional quality controls were applied to the data before the association analysis: (i) visual and/or manual inspection of each cluster plot, that is, the genotype assignment and cluster separation were manually checked. For the Sequenom data, we used Evoker v1.0 (see URLs) 50 to examine the cluster plots. For SNPlex, genotype assignments were verified visually using the GeneMapper 4.0 (Applied Biosystems) software, and for TaqMan, we used the SDS v2.3 progam (Applied Biosystems). The aim of examining a cluster plot is twofold: to determine whether a given SNP has been genotyped well (in particular, whether clear distinct clusters can be identified on the plot that would correspond to the three genotypes) and to determine whether the calling algorithm has called the clusters correctly. If both of these requirements were fulfilled, as genotype counts can usually be assumed to be sufficiently accurate. If not, any observed disease association of such a SNP may be due to incorrect genotype counts. (ii) Call rate (genotype success rate) in each case or control panel greater than 95%. (iii) Hardy-Weinberg P > 10 −4 in each healthy control sample.
Replication and joint P values were calculated using the weighted z statistic described above.
Heritability analyses.
We estimated the fraction of additive genetic variance explained using the liability threshold model of Risch 51 , which assumes an additive effect at each locus and which shifts the mean of a normally distributed distribution of disease liability for each genotype class. Given the lack of evidence for gene-gene interaction among our 71 loci, we consider these contributions to be additive. We assumed a prevalence of Crohn's disease of 4 per 1,000 and a total narrow-sense heritability of 50% (ref. 52) . Results of this analysis are shown in Figure 2 .
Interaction analyses. To test for pairwise interactions among the 71 confirmed associated loci, we performed an interaction meta-analysis using the approach described below. Each of the six scans performed an identical pairwise scan of the 71 × 70/2 pairs of SNPs in Tables 1 and 2 using logistic regression in which three terms (dosage of SNP 1, dosage of SNP 2 and an additive interaction term) were included. The significance of this interaction terms was represented by a directional z-score which was then combined across all six studies using a sample-size-weighted combination of z-scores. The overall combined quantile-quantile plot resulting from this analysis showed no deviation from the null (Supplementary Fig. 3) , and no results were significant when considering the number of tests performed.
